Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Structure-Based Development of 3,5-Dihydroxybenzoyl-Hydrazineylidene As Tyrosinase Inhibitor; in Vitro And in Silico Study
Ismaeil Haririan
Ismaeil Haririan

Professor of Pharmaceutics

Department Pharmaceutical Biomaterials

School of Pharmacy

Medical Biomaterials Research Center

Tehran University of Medical Sciences

All Documents